What we know about Covid-19 and blood clotting iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.
By Reuters Staff
3 Min Read
CAPE TOWN (Reuters) - South Africa will ramp up home delivery of medicines to patients and expand the use of chest X-rays for tuberculosis (TB) screening in communities as it looks to contain new infections since the COVID-19 pandemic severely disrupted health services, the health minister said on Friday.
FILE PHOTO: Healthcare workers chat at a temporary ward set up during the coronavirus disease (COVID-19) outbreak, at Steve Biko Academic Hospital in Pretoria, South Africa, January 19, 2021. Phill Magakoe/Pool via REUTERS/File Photo
Designated by the World Health Organization as a high burden country, South Africa registers around 60,000 deaths from TB each year, making it the country’s leading infectious disease killer closely intertwined with one of the world’s highest rates of HIV/Aids.
Sygnia Asset Management is developing a new vaccine and South Africans are once again connecting the dots between CEO Magda Wierzycka and President Cyril Ramaphosa.
Sygnia, an investor in Oxford Sciences Innovation, approached the Serum Institute of India (SII) to run trials on a new set of jabs. The aim is to produce 10 million inoculations for South Africa citizens.
Magda Wierzycka, Ramaphosa and the vaccine
Vaccine battle
Earlier this week, Wierzycka told
Moneyweb editor Ryk van Niekerk that the Ministry of Health should use AstraZeneca on medical personnel in order to have a “larger sample size to observe on a live basis”.
JOHANNESBURG - South Africa is considering giving a COVID-19 vaccine that is still in the testing phase to health workers, after suspending the rollout .
JOHANNESBURG — South Africa is considering giving a covid-19 vaccine that is still in the testing phase to health workers, after suspending the rollout of another shot that preliminary data indicated is not effective at preventing mild to moderate illness from the variant dominant in the country. The country is